Enisamium Inhibits SARS-CoV-2 RNA Synthesis

Enisamium Inhibits SARS-CoV-2 RNA Synthesis

Pandemic SARS-CoV-2 causes a mild to severe respiratory disease called coronavirus disease 2019 (COVID-19). While control of the SARS-CoV-2 spread partly depends on vaccine-induced or naturally acquired protective herd immunity, antiviral strategies are still needed to manage COVID-19. Enisamium is...

Full description

Bibliographic Details
Main Authors: Stefano Elli, Denisa Bojkova, Marco Bechtel, Thomas Vial, David Boltz, Miguel Muzzio, Xinjian Peng, Federico Sala, Cesare Cosentino, Andrew Goy, Marco Guerrini, Lutz Müller, Jindrich Cinatl, Victor Margitich, Aartjan J. W. te Velthuis
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Biomedicines
Subjects:
COVID-19
SARS-CoV-2
molecular dynamics simulation
RNA polymerase
FAV00A
Amizon
Online Access:https://www.mdpi.com/2227-9059/9/9/1254

Internet

https://www.mdpi.com/2227-9059/9/9/1254

Similar Items